Skip to main content
. Author manuscript; available in PMC: 2015 Jun 16.
Published in final edited form as: Eur J Pharm Sci. 2014 Jan 28;57:152–163. doi: 10.1016/j.ejps.2014.01.009

Table 3b.

Proposed relevant bioperformance dissolution methodology (apparatus and media).

BCS sub-classification Gastric medium Consider gastric compartment? Intestinal luminal medium Consider absorption compartment?a
I 250 ml PGBe Nob 900 ml PIBc No
IIa Yesd 100 ml PIB Yes
IIb Yesd 100 ml PIB Yes
IIc Yesd 100 ml PIB + bile acids/lipid Yes
III Nob 100 ml PIB No
IVa Yesd 100 ml PIB Yes
IVb Yesd 100 ml PIB Yes
IVc Yesd 100 ml PIB + bile acids/lipid Yes
a

An organic medium (such as 1-octanol) can be used for the absorption compartment when logDpH6.5 > than about 0.5–1 (Mudie et al., 2012). Otherwise, an alternative such as an artificial or caco2 membrane (Kataoka et al., 2003, 2006, 2012, 2013) may be used. Surface area of organic medium (or membrane) to volume ratio of luminal medium (A/V) must be chosen properly (Mudie et al., 2012).

b

Pretreat dosage form with gastric medium for 15 min and subsequently transfer dosage form + gastric medium to intestinal luminal medium. Determine contribution of gastric emptying rate to delay in onset of appearance in plasma computationally.

c

Physiological intestinal buffer (PIB), which should be pH 6.5 bicarbonate buffer with a buffer concentration between about 5–15 mM, or an aqueous buffer with an equivalent buffer capacity.

d

Empty gastric contents in a first order manner with a rate coefficient of 2.8 h−1 (half-emptying time of 15 min).

e

Physiological gastric buffer (PGB), which is 0.01 N HCl.